Aceglatone, an antineoplastic agent, is a beta-glucuronidase inhibitor. Aceglatone is a compound that inhibits colon carcinogenesis and prevents the induction of colon cancer by inhibiting the hydrolysis of glucuronides. Aceglatone reduces cell proliferation, induces apoptosis and inhibits DNA synthesis in human colon cancer cells[1].
Molekulargewicht:
258.18
CAS Nummer:
[642-83-1]
Formel:
C10H10O8
Target-Kategorie:
Apoptosis,DNA/RNA Synthesis,beta-glucuronidase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
